LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Biologics/3D Bioprinting Creates Blood Vessels
Biologics

3D Bioprinting Creates Blood Vessels

March 23, 2016 2 min read Premium comments

Advertisement

3D Bioprinting Creates Blood Vessels
3D Printing Blood Vessels / Courtesy of the Wyss Institute at Harvard University
Secondary

A group of researchers has taken bio-printing to a new level. They have found a way to 3D bioprint thick vascularized tissue constructs composed of human stem cells, extracellular matrix, and circulatory channels lined with endothelial blood vessel cells. The resulting network of vasculature can channel fluids, nutrients and cell growth factors, for the first time, throughout tissues.

As Jennifer A. Lewis, Sc.D., senior author on the study and the Hansörg Wyss Professor of Biologically Inspired Engineering at Harvard’s John A. Paulson School for Engineering and Applied Sciences (SEAS), explained, “This latest work extends the capabilities of our multi-material bioprinting platform to thick human tissues, bringing us one step closer to creating architectures for tissue repair and regeneration.”

Until now, scaling up human tissues built of cell types has been limited by an inability to embed life-sustaining vascular networks. Lewis and her team solved this problem by increasing the tissue thickness nearly tenfold. They combined vascular plumbing with living cells and an extracellular matrix which enabled the structures to function as living tissues. They showed that their 3D bioprinted tissues could function as living tissue architectures for upwards of six weeks.

“This research will help to establish the fundamental scientific understanding required for bioprinting of vascularized living tissues, ” said Zhijian Pei, Ph.D., National Science Foundation Program Director for the Directorate for Engineering Division of Civil, Mechanical and Manufacturing Innovation, which funded the project.

According to Medical Press, Lewis uses a printed silicone mold to house and plumb the printed tissue structure. “Inside this mold, a grid of vascular channels is printed first, over which ink containing living stem cells is then printed. The inks are self-supporting and strong enough to hold shape as the structure’s size increases with each layer of deposition. At intersections meeting within the foundational vascular grid, vertical vascular pillars are printed, which interconnect a network of microvessels. After printing, a liquid composed of fibroblasts and extracellular matrix fills in the open regions around the 3D printed tissue, cross linking the entire structure.”

The resulting structure has a quantity of blood vessels, and can be immediately perfused with nutrients to ensure survival of the cells.

Team members for this breakthrough research came from the Wyss Institute for Biologically Inspired Engineering at Harvard University and the Harvard John A. Paulson School for Engineering and Applied Sciences. The full story is reported in the journal Proceedings of the National Academy of Sciences.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy